GetTopicDetailResponse(id=05c0105e807c, topicName=氯巴占, introduction=氯巴占, content=氯巴占治療難治性癲癇, image=null, comments=4, allHits=1454, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=4754896, adminEncryptionId=f63e4754896, adminName=俠膽醫(yī)心, createdBy=f63e4754896, createdName=俠膽醫(yī)心, createdAvatar=, createdTime=Wed Apr 05 03:04:22 CST 2023, time=2023-04-05, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=118772, tagList=[TagDto(tagId=118772, tagName=氯巴占)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2239982, encodeId=bd2022399824f, content=<a href='/topic/show?id=09f0e1554e6' target=_blank style='color:#2F92EE;'>#癲癇#</a> <a href='/topic/show?id=05c0105e807c' target=_blank style='color:#2F92EE;'>#氯巴占#</a>, objectTitle=“氯巴占”進(jìn)醫(yī)保了，臨床如何正確使用？, objectType=article, longId=852616, objectId=3ad98526161e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021638994_4754896.webp, objectUrl=/article/show_article.do?id=3ad98526161e, replyNumber=0, likeNumber=48, createdTime=2024-11-29, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=3ad98526161e, moduleTitle=“氯巴占”進(jìn)醫(yī)保了，臨床如何正確使用？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3ad98526161e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2126236, encodeId=d2c021262365c, content=<a href='/topic/show?id=43bc1048492e' target=_blank style='color:#2F92EE;'>#頑固性癲癇#</a>救命藥<a href='/topic/show?id=05c0105e807c' target=_blank style='color:#2F92EE;'>#氯巴占#</a>, objectTitle=頑固性癲癇救命藥氯巴占，國產(chǎn)藥上市, objectType=article, longId=767257, objectId=0e96e672576b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230411/5da40d95a4f4416fba4f1bb14b4ffb9d.jpg, objectUrl=/article/show_article.do?id=0e96e672576b, replyNumber=0, likeNumber=212, createdTime=2023-04-16, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=香港, moduleDTOList=[ModuleDTO(moduleId=0e96e672576b, moduleTitle=頑固性癲癇救命藥氯巴占，國產(chǎn)藥上市, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0e96e672576b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2123795, encodeId=4c132123e95d9, content=<a href='/topic/show?id=05c0105e807c' target=_blank style='color:#2F92EE;'>#氯巴占#</a>治療<a href='/topic/show?id=78b298640cb' target=_blank style='color:#2F92EE;'>#難治性癲癇#</a>, objectTitle=氯巴占治療難治性癲癇專家共識（2022）, objectType=guider, longId=18811, objectId=6a2961c00261e2ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=6a2961c00261e2ec, replyNumber=0, likeNumber=205, createdTime=2023-04-05, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6a2961c00261e2ec, moduleTitle=氯巴占治療難治性癲癇專家共識（2022）, moduleType=guider, hrefUrl=http://ermita.cn/guideline/show_article.do?id=6a2961c00261e2ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2123797, encodeId=10e62123e97a3, content=<a href='/topic/show?id=05c0105e807c' target=_blank style='color:#2F92EE;'>#氯巴占#</a>, objectTitle=氯巴占臨時進(jìn)口工作方案, objectType=guider, longId=17519, objectId=37f2a1c002a8800e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=37f2a1c002a8800e, replyNumber=0, likeNumber=102, createdTime=2023-04-05, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=37f2a1c002a8800e, moduleTitle=氯巴占臨時進(jìn)口工作方案, moduleType=guider, hrefUrl=http://ermita.cn/guideline/show_article.do?id=37f2a1c002a8800e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2123798, encodeId=9f522123e9808, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>批準(zhǔn)<a href='/topic/show?id=05c0105e807c' target=_blank style='color:#2F92EE;'>#氯巴占#</a>（clobazam）治療<a href='/topic/show?id=521095e2511' target=_blank style='color:#2F92EE;'>#重型癲癇#</a><a href='/topic/show?id=78b298640cb' target=_blank style='color:#2F92EE;'>#難治性癲癇#</a>, objectTitle=FDA批準(zhǔn)氯巴占（clobazam）治療重型癲癇, objectType=article, longId=3260, objectId=3ea83260c5, topicUrl=null, isHasObj=0, objectCover=, objectUrl=/article/show_article.do?id=3ea83260c5, replyNumber=0, likeNumber=151, createdTime=2023-04-05, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3ea83260c5, moduleTitle=FDA批準(zhǔn)氯巴占（clobazam）治療重型癲癇, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3ea83260c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
俠膽醫(yī)心
2023-04-05發(fā)表于上海
